Press release
Rising Pneumonia Cases Fuel Demand For Advanced Treatments: Powering Innovation and Expansion in the Global Pneumonia Therapeutics Market by 2025
Pneumonia Therapeutics
What Is the Expected CAGR for the Pneumonia Therapeutics Market Through 2025?
The market encompassing pneumonia therapeutics has experienced swift expansion lately, projected to increase from a valuation of $10.35 billion in 2024 to $11.46 billion the following year, reflecting a compound annual growth rate of 10.7%. This upward trajectory in the past has been fueled by several factors: a higher incidence of strains resistant to medication, greater consciousness regarding how to avoid pneumonia, an augmentation in the count of aging individuals and those with weakened immune systems, widespread immunization initiatives, and enhancements made to medical facilities.
What's the Projected Size of the Global Pneumonia Therapeutics Market by 2029?
Forecasting significant expansion, the market for pneumonia therapeutics anticipates swift advancement, projected to achieve a valuation of $17.11 billion by 2029, reflecting a compound annual growth rate of 10.6% over the projection timeframe. This upward trajectory is fueled by several factors, including the proliferation of antibiotic-resistant pathogens, the mounting incidence of pneumonia within geriatric cohorts, the broader utilization of remote medical consultation for initial disease identification, escalating healthcare spending across developing economies, augmented investment in infectious disease investigation, and intensified public knowledge initiatives. Key developments shaping the market during this period will encompass the creation of monoclonal antibody treatments, the increasing deployment of inhaled antibiotic formulations, progress in formulating vaccines based on messenger RNA technology, the integration of artificial intelligence for diagnostic instruments, the uptake of therapies focused on the host response, the emergence of new immunomodulatory agents, and improvements in swift, on-site diagnostic systems.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pneumonia-therapeutics-global-market-report
Top Growth Drivers in the Pneumonia Therapeutics Industry: What's Accelerating the Market?
Anticipated expansion in the occurrence of pneumonia is set to fuel the expansion of the market for pneumonia treatments moving ahead.Pneumonia is characterized as an inflammation of the lung air sacs resulting from an infection, frequently manifesting through indicators like coughing fits, elevated temperature, and labored respiration.This escalation in pneumonia instances can be linked to several contributing elements, including the aging demographic, atmospheric contamination, tobacco use, compromised immunity, resistance to antimicrobials, and the circulation of respiratory illnesses such as influenza or COVID-19.Therapies for pneumonia function by confronting the underlying source of the infection-be it fungal, viral, or bacterial-through specialized pharmaceuticals, simultaneously aiding recuperation via anti-inflammatory medications, symptom alleviation, and the provision of supplemental oxygen.To illustrate this impact, data from the National Center for Biotechnology Information, a US governmental body, indicated in January 2023 that pneumonia impacts roughly 120 million individuals worldwide each year, leading to an estimated 1.3 million fatalities.Furthermore, almost 80 percent of fatal pediatric pneumonia cases are concentrated among youngsters under the age of two residing in emerging nations.Consequently, this escalating incidence rate of pneumonia is a primary impetus behind the growth trajectory of the pneumonia therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21258&type=smp
What Trends Will Shape the Pneumonia Therapeutics Market Through 2029 and Beyond?
Key players within the pneumonia treatment arena are concentrating their efforts on formulating novel drug compositions and therapeutic approaches, notably incorporating antibiotic agents to combat growing antibiotic resistance and enhance recovery rates for patients.Antibiotic medications constitute a category of pharmaceuticals engineered explicitly for combating infections caused by bacteria.As a recent illustration, in the month of June 2024, the Indian pharmaceutical entity Orchid Pharma Limited entered into a partnership with fellow Indian pharmaceutical firm Cipla Limited for the launch of cefepime-enmetazobactam, an antibiotic pairing intended for managing complicated infections such as pneumonia and urinary tract infections, especially in cases exhibiting resistance to previously used drugs; this specific combination is vital for achieving efficacy against bacterial resistance, thereby ensuring successful treatment while reducing reliance on more potent antimicrobial agents.
What Are the Main Segments in the Pneumonia Therapeutics Market?
The pneumonia therapeuticsmarket covered in this report is segmented -
1) By Product: Drugs; Vaccine; Oxygen Therapy
2) By Infection: Hospital-Acquired Pneumonia (HAP); Community-Acquired Pneumonia (CAP); Ventilator-Associated Pneumonia (VAP)
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By End Use: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Drugs: Antibiotics; Antiviral Drugs; Antifungal Drugs; Corticosteroids; Other Drugs
2) By Vaccine: Pneumococcal Vaccines; Haemophilus Influenzae Type B (Hib) Vaccines; Influenza Vaccines; Other Vaccines
3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC); Non-Invasive Ventilation (NIV); Mechanical Ventilation; Other Oxygen Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21258&type=smp
Which Top Companies are Driving Growth in the Pneumonia Therapeutics Market?
Major companies operating in the pneumonia therapeutics market are Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc., Tergene Biotech Limited.
Which Regions Will Dominate the Pneumonia Therapeutics Market Through 2029?
North America was the largest region in the pneumonia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumonia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21258
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Pneumonia Cases Fuel Demand For Advanced Treatments: Powering Innovation and Expansion in the Global Pneumonia Therapeutics Market by 2025 here
News-ID: 4279444 • Views: …
More Releases from The Business Research Company
Global Parkinson's Disease Market Expected to Achieve 8.1% CAGR by 2029: Growth …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Parkinson's Disease Market Size By 2025?
The market for treating Parkinson's disease has experienced significant expansion lately; its valuation is projected to climb from three point thirty-four billion dollars in 2024 to three point sixty-two billion dollars the following year, reflecting an eight point two…
Oral Mucositis Market Expansion Continues, with Forecast Valuation of $2.06 Bill …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Oral Mucositis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Significant upward momentum has characterized the oral mucositis market recently, projecting an expansion from its 2024 valuation of $1.44 billion to $1.55 billion by 2025, reflecting a compound annual growth rate of 7.7%. This historical…
Global Myocarditis Disease Market: Major Trends Reshaping the Future of the Indu …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Myocarditis Disease Industry Market Size Be by 2025?
The valuation of the myocarditis affliction sector has demonstrated vigorous expansion lately, escalating from a figure of $1.5 billion across 2024 to an anticipated $1.6 billion by 2025, reflecting a consistent annual uplift measured at 6.5 percent. This…
Steady Expansion Forecast for Lewy Body Dementia Market, Projected to Reach $1.5 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Lewy Body Dementia Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market valuation for Lewy Body Dementia has experienced a significant upswing lately, projected to move from an established $1.12 billion in 2024 to $1.2 billion by 2025, reflecting a steady compound annual growth…
More Releases for Pneumonia
Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve …
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903
With the rise of antibiotic resistance, aging populations, and increased use of ventilators in…
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
